Speaker Info
HIV ANTIVIRALS AND OUTCOMES
NUCLEOSIDES AND DARUNAVIR/DOLUTEGRAVIR IN AFRICA (NADIA) TRIAL: OUTCOMES AT 96 WEEKS
Nicholas Paton
National University of Singapore, Singapore, Singapore
--:--:--
--:--:--
Placeholder for warning

loading...